A278650 logo

HLB bioStep Co.,Ltd. Stock Price

KOSDAQ:A278650 Community·₩110.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A278650 Share Price Performance

₩1,307.00
-848.00 (-39.35%)
₩1,307.00
-848.00 (-39.35%)
Price ₩1,307.00

A278650 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

2 Risks
0 Rewards

HLB bioStep Co.,Ltd. Key Details

₩66.0b

Revenue

₩18.4b

Cost of Revenue

₩47.6b

Gross Profit

₩56.8b

Other Expenses

-₩9.2b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-109.43
72.07%
-14.00%
26.4%
View Full Analysis

About A278650

Founded
2012
Employees
147
CEO
In-Sung Jeong
WebsiteView website
hlbbiostep.com

HLB bioStep Co.,Ltd. provides various test services. It offers platform technology services, such as cell-enzyme-based screening, xenograft assay, mitogenic effect test, vaccine antigen, antibody titration, cytokine, MRNA expression, trachea relaxation assay, carrageenan, adjuvant induced paw edema, antipyretic, anti-pain test, isolated blood vessel screening, fibrin plate lysis screening, ferric chloride induced model, food diet induced model, gastric acid secretion, emesis model, MIC test, post antibody effect, enzyme assay, systemic, local infection model, PK study, chemical, transgenic animal, osteoblast-like cell line screening, bone formation marker, and biomarker. The company also provides pharmacokinetic/toxico study, toxicology study, and biological drug; and toxic/clinical pathology services. The company was formerly known as KNOTUS Co.,Ltd. The company was founded in 2012 and is based in Incheon, South Korea.

Recent A278650 News & Updates

Recent updates

No updates